Galectin Therapeutics | GALT - 净收入





净收入 更改 日
AbbVie USD 695M 1.12B 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Galectin Therapeutics USD -12.37M 880K 2024-06
Gilead Sciences USD 2.18B 869M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Incyte USD 303.33M 4.05M 2026-03
Merck USD -4.24B 7.2B 2026-03